Abstract
P-338 Second-line treatment with modified FOLFIRINOX in patients with pancreatic adenocarcinoma who have failed first-line treatment with gemcitabine and nab-paclitaxel
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have